| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |